Lonza Group AG
ISIN: CH0013841017 | Ticker: LONN | LEI: 549300EFW4H2TCZ71055
Country: Switzerland
Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.
Year founded1897
Served areaWorldwide
Headcount16,218
HeadquartersMünchensteinerstrasse 38, 4002 Basel – Switzerland
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 15.11.23 | None | Executive member | Buy | CHF 7,088.00 |
| 01.11.23 | None | Executive member | Buy | CHF 95,927.90 |
| 23.10.23 | None | Executive member | Buy | CHF 327.30 |
| 19.10.23 | None | Executive member | Buy | CHF 19,847.60 |
| 18.10.23 | None | Non-Executive member | Buy | CHF 495,880.00 |
| 18.10.23 | None | Executive member | Buy | CHF 19,481.00 |
| 23.05.23 | None | Executive member | Sell | CHF 533,504.40 |
| 19.05.23 | None | Executive member | Sell | CHF 298,737.20 |
| 27.01.22 | None | Executive member | Buy | CHF 59,163.24 |
CH0013841017
LEI549300EFW4H2TCZ71055
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustrySMI
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.